Form 6-K NOVARTIS AG For: Jun 30

Go back to Form 6-K NOVARTIS AG For: Jun 30

Novartis (NVS) Tops Q2 EPS by 4c

July 19, 2022 7:21 AM EDT

Novartis (NYSE: NVS) reported Q2 EPS of $1.56, $0.04 better than the analyst estimate of $1.52. Revenue for the quarter came in at $12.78 billion versus the consensus estimate of $12.93 billion.

2022... More